Insulet earnings were $302.8M for the trailing 12 months ending Mar 31, 2026, with -25.1% growth year over year. The latest PODD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $91.1M, down 10.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PODD reported annual earnings of $247.1M, with -40.9% growth. The next PODD earnings date is Aug 5, 2026.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Invalid Date, Insulet (NASDAQ: PODD) reported Q1 2026 earnings per share (EPS) of $1.30, up 160% year over year. Total PODD earnings for the quarter were $91.10 million. In the same quarter last year, Insulet's earnings per share (EPS) was $0.50.
The next PODD earnings call is Invalid Date. Add PODD to your watchlist to be reminded of Insulet's next earnings date.
Is Insulet profitable or losing money?
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $302.80 million, a 24.71% decrease year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Invalid Date, Insulet's earnings has grown -25.09% year over year. This is 31.3 percentage points lower than the US Medical Devices industry earnings growth rate of 6.21%. PODD earnings in the past year totalled $302.80 million.
What are Insulet's earnings expectations?
The current EPS estimate for Insulet's earnings report in Invalid Date is $1.38.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.